SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-22-003482
Filing Date
2022-09-21
Accepted
2022-09-21 08:00:25
Documents
11
Period of Report
2022-09-21

Document Format Files

Seq Description Document Type Size
1 6-K zk2228489.htm 6-K 28175
2 OPINION OF YIGAL ARNON & CO. exhibit_5-1.htm EX-5.1 10692
3 OPINION OF MCDERMOTT WILL & EMERY LLP exhibit_5-2.htm EX-5.2 13678
4 FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF SEPTEMBER 18, 2022 BETWEEN BIO exhibit_10-1.htm EX-10.1 189370
5 FORM OF WARRANT TO BE ISSUED BY BIOLINERX LTD. ON SEPTEMBER 21, 2022 exhibit_10-2.htm EX-10.2 86858
6 FORM OF PLACEMENT AGENT WARRANT TO BE ISSUED BY BIOLINERX LTD. ON SEPTEMBER 21, exhibit_10-3.htm EX-10.3 83942
7 image00001.jpg GRAPHIC 22619
8 image00003.jpg GRAPHIC 14604
9 image00004.jpg GRAPHIC 186631
10 image00009.jpg GRAPHIC 9901
11 image00010.jpg GRAPHIC 3664
  Complete submission text file 0001178913-22-003482.txt   741434
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 221255030
SIC: 2834 Pharmaceutical Preparations